Eutylone
β-Keto-1,3-benzodioxolyl-N-ethylbutanamine is a stimulant compound developed in the 1960s, which has been reported as a novel designer drug.Sweden's public health agency suggested classifying Eutylone as a hazardous substance, on September 25, 2019.
